Michael Abrams

Insider Reports History

Location
Raynham, MA
Signature
/s/ Michael Abrams
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Abrams:

Company Role Class Num Shares Value Price $ Report Date Ownership
NRX Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 50,000 $10,000 $0.2000 07 Feb 2025 Direct
Arch Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 10,292 $2,830 $0.2750 31 Aug 2023 Direct
Arch Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 900,000 10 Nov 2022 Direct
Arch Therapeutics, Inc. CHIEF FINANCIAL OFFICER Warrants (right to buy) 20,584 31 Aug 2023 Direct

Insider Reports Filed by Michael Abrams

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRXP NRX Pharmaceuticals, Inc. 07 Feb 2025 1 $0 4 Chief Financial Officer 11 Feb 2025, 17:00
NRXP NRX Pharmaceuticals, Inc. 18 Nov 2024 0 $0 3 Chief Financial Officer 22 Nov 2024, 13:44
ARTHQ Arch Therapeutics, Inc. 31 Aug 2023 2 +$2,830 4 CHIEF FINANCIAL OFFICER 08 Sep 2023, 18:47
ARTHQ Arch Therapeutics, Inc. 10 Nov 2022 1 $0 4 CHIEF FINANCIAL OFFICER 10 Nov 2022, 20:49
ARTHQ Arch Therapeutics, Inc. 06 Jul 2022 3 $0 4 CHIEF FINANCIAL OFFICER 08 Jul 2022, 16:57
ARTHQ Arch Therapeutics, Inc. 27 Sep 2021 1 $0 4 Chief Financial Officer 01 Oct 2021, 08:17
ARTHQ Arch Therapeutics, Inc. 10 May 2021 0 $0 3 CFO and Treasurer 10 May 2021, 08:02